Clinical Trial

Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes

Study acronym: COLOR-REAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter, prospective, non-interventional real-world study to evaluate the clinical outcomes of biweekly cofrogliptin versus daily linagliptin as an add-on therapy in Chinese adult T2D patients.
Trial Details
NCT Number NCT07198932
Lead Sponsor Yanbing Li
Conditions Type 2 Diabetes
Enrollment 594 participants
Start Date 2025-10-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-30